CL2015000902A1 - Compuestos derivados de benzamidas, inhibidores del receptor 2x7 purinergico (p2x7); y composicion farmaceutica que los comprende. - Google Patents

Compuestos derivados de benzamidas, inhibidores del receptor 2x7 purinergico (p2x7); y composicion farmaceutica que los comprende.

Info

Publication number: CL2015000902A1
Authority: CL; Chile
Prior art keywords: purinergic; benzamides; pharmaceutical composition; compounds derived; receptor inhibitors
Prior art date: 2012-10-12

Application number

CL2015000902A

Other languages

English (en)

Inventor

John Paul Kilburn

Lars Kyhn Rasmussen

Mikkel Jessing

Eman Mohammed Eldemenky

Bin Chen

Yu Jiang

Allen T Hopper

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-10-12

Filing date

2015-04-09

Publication date

2015-08-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49551580&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015000902(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-04-09 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2015-08-28 Publication of CL2015000902A1 publication Critical patent/CL2015000902A1/es

Links

229940054066 benzamide antipsychotics Drugs 0.000 title 1
150000003936 benzamides Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
230000001696 purinergic effect Effects 0.000 title 1
108091006082 receptor inhibitors Proteins 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/66—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/73—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/75—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyridine Compounds (AREA)
Hydrogenated Pyridines (AREA)
Pyrane Compounds (AREA)

CL2015000902A 2012-10-12 2015-04-09 Compuestos derivados de benzamidas, inhibidores del receptor 2x7 purinergico (p2x7); y composicion farmaceutica que los comprende. CL2015000902A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201261713113P	2012-10-12	2012-10-12

Publications (1)

Publication Number	Publication Date
CL2015000902A1 true CL2015000902A1 (es)	2015-08-28

Family

ID=49551580

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2015000902A CL2015000902A1 (es)	2012-10-12	2015-04-09	Compuestos derivados de benzamidas, inhibidores del receptor 2x7 purinergico (p2x7); y composicion farmaceutica que los comprende.

Country Status (42)

Country	Link
US (4)	US9102591B2 (es)
EP (1)	EP2906546B1 (es)
JP (2)	JP6515409B2 (es)
KR (1)	KR20150067188A (es)
CN (1)	CN104884445B (es)
AP (1)	AP2015008406A0 (es)
AR (1)	AR092973A1 (es)
AU (1)	AU2013328584B2 (es)
BR (1)	BR112015008117A2 (es)
CA (1)	CA2887096C (es)
CL (1)	CL2015000902A1 (es)
CR (1)	CR20150171A (es)
CY (1)	CY1120008T1 (es)
DK (1)	DK2906546T3 (es)
DO (1)	DOP2015000076A (es)
EA (1)	EA026396B1 (es)
EC (1)	ECSP15013883A (es)
ES (1)	ES2662523T3 (es)
GE (1)	GEP201706621B (es)
HR (1)	HRP20180272T1 (es)
HU (1)	HUE038223T2 (es)
IL (1)	IL237914A0 (es)
LT (1)	LT2906546T (es)
MA (1)	MA37990B1 (es)
ME (1)	ME02982B (es)
MX (1)	MX369717B (es)
NI (1)	NI201500050A (es)
NO (1)	NO2851818T3 (es)
NZ (1)	NZ630830A (es)
PE (1)	PE20150709A1 (es)
PH (1)	PH12015500746A1 (es)
PL (1)	PL2906546T3 (es)
PT (1)	PT2906546T (es)
RS (1)	RS56925B1 (es)
RU (1)	RU2015113320A (es)
SG (1)	SG11201502680QA (es)
SI (1)	SI2906546T1 (es)
SM (1)	SMT201800136T1 (es)
TN (1)	TN2015000107A1 (es)
TR (1)	TR201802992T4 (es)
TW (1)	TWI598325B (es)
WO (1)	WO2014057078A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI598325B (zh) *	2012-10-12	2017-09-11	Ｈ朗德貝克公司	苯甲醯胺類
TW201427947A (zh) *	2012-10-12	2014-07-16	Lundbeck & Co As H	環狀胺
KR102232742B1 (ko)	2012-12-12	2021-03-26	이도르시아 파마슈티컬스 리미티드	Ｐ２ｘ７ 수용체 길항제로서의 인돌 카르복사미드 유도체
WO2014097140A1 (en)	2012-12-18	2014-06-26	Actelion Pharmaceuticals Ltd	Indole carboxamide derivatives as p2x7 receptor antagonists
JP6282016B2 (ja)	2013-01-22	2018-02-21	イドーシアファーマシューティカルズリミテッドＩｄｏｒｓｉａＰｈａｒｍａｃｅｕｔｉｃａｌｓＬｔｄ	Ｐ２ｘ７受容体アンタゴニストとしての複素環アミド誘導体
JP6282017B2 (ja)	2013-01-22	2018-02-21	イドーシアファーマシューティカルズリミテッドＩｄｏｒｓｉａＰｈａｒｍａｃｅｕｔｉｃａｌｓＬｔｄ	Ｐ２ｘ７受容体アンタゴニストとしての複素環アミド誘導体
CN105503787A (zh) *	2015-12-31	2016-04-20	阜阳欣奕华材料科技有限公司	一种索非布韦中间体的纯化方法
CN106366056B (zh) *	2016-08-26	2018-12-11	常州市阳光药业有限公司	3-氨甲基四氢呋喃的制备方法
AU2018235561B2 (en) *	2017-03-13	2020-06-18	Asahi Kasei Pharma Corporation	Tetrahydroquinoline derivatives as P2X7 receptor antagonists
CR20200464A (es)	2018-03-08	2021-04-14	Incyte Corp	Compuestos diólicos de aminopirazina como inhibidores de pi3k-y
WO2020010003A1 (en)	2018-07-02	2020-01-09	Incyte Corporation	AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
MA55805A (fr)	2019-05-03	2022-03-09	Flagship Pioneering Innovations V Inc	Métodes de modulation de l'activité immunitaire
EP4238974A4 (en) *	2020-10-28	2024-10-23	Adlai Nortye Biopharma Co., Ltd.	HIGH ACTIVITY WNT PATHWAY INHIBITOR COMPOUND
EP4015039A1 (en) *	2020-12-18	2022-06-22	AXXAM S.p.A.	Heterocyclic derivatives as p2x7 receptor antagonists
EP4717089A3 (en) *	2021-08-02	2026-06-24	Syngenta Crop Protection AG	Microbiocidal pyrazole derivatives

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1445707A1 (de)	1962-05-05	1969-03-13	Hoechst Ag	Piperidinverbindungen und Verfahren zu ihrer Herstellung
US3435038A (en) *	1965-06-01	1969-03-25	Sandoz Ag	5,6,7,9,10,14b-hexahydroisoquinolo (2,1-d) benzo (1,4) diazepines
US6632836B1 (en) *	1998-10-30	2003-10-14	Merck & Co., Inc.	Carbocyclic potassium channel inhibitors
US6303637B1 (en) *	1998-10-30	2001-10-16	Merck & Co., Inc.	Heterocyclic potassium channel inhibitors
US6194458B1 (en) *	1998-10-30	2001-02-27	Merck & Co., Inc.	Benzamide potassium channel inhibitors
SE0003476D0 (sv) *	2000-09-28	2000-09-28	Astrazeneca Ab	Compounds
TW200300083A (en)	2001-11-12	2003-05-16	Pfizer Prod Inc	Benzamide, heteroarylamide and reverse amides
PA8557501A1 (es)	2001-11-12	2003-06-30	Pfizer Prod Inc	Benzamida, heteroarilamida y amidas inversas
TW200403058A (en) *	2002-04-19	2004-03-01	Bristol Myers Squibb Co	Heterocyclo inhibitors of potassium channel function
PA8591801A1 (es) *	2002-12-31	2004-07-26	Pfizer Prod Inc	Inhibidores benzamidicos del receptor p2x7.
EP1626962B1 (en) *	2003-05-12	2007-02-28	Pfizer Products Inc.	Benzamide inhibitors of the p2x7 receptor
KR20060073930A (ko)	2003-08-08	2006-06-29	버텍스 파마슈티칼스 인코포레이티드	통증 치료시 나트륨 또는 칼슘 채널 차단제로서 유용한헤테로아릴아미노설포닐페닐 유도체
TWI368482B (en)	2003-12-19	2012-07-21	Bayer Sas	New 2-pyridinylethylbenzamide derivatives
EP1729772B8 (en) *	2004-03-24	2017-04-19	Merck Sharp & Dohme Corp.	Heteroaryl piperidine glycine transporter inhibitors
BRPI0512915A (pt) *	2004-06-29	2008-04-15	Warner Lambert Co	terapias de combinação utilizando inibidores benzamida do receptor p2x7
AU2005317846B2 (en) *	2004-12-21	2011-12-08	Merck Sharp & Dohme Limited	Piperidine and azetidine derivatives as GlyT1 inhibitors
EP1844003A4 (en) *	2005-01-27	2010-09-22	Astrazeneca Ab	NEW BIAROMATIC COMPOUNDS AS INHIBITORS OF THE P2X7 RECEPTOR
CA2611376C (en) *	2005-06-13	2013-09-10	Merck Sharp & Dohme Limited	Therapeutic agents
ES2320042T3 (es)	2005-10-19	2009-05-18	F. Hoffmann-La Roche Ag	Inhibidores de transcriptasa reversa con nucleosidos de n-fenil fenilacetamida.
JP2009057282A (ja)	2005-12-19	2009-03-19	Astellas Pharma Inc	カルボン酸誘導体又はその塩
TWI435863B (zh)	2006-03-20	2014-05-01	Nihon Nohyaku Co Ltd	Ｎ-２-（雜）芳基乙基甲醯胺衍生物及含該衍生物之蟲害防治劑
WO2009003672A2 (en) *	2007-07-02	2009-01-08	Syngenta Participations Ag	Novel microbiocides
AU2008345225A1 (en) *	2007-12-21	2009-07-09	University Of Rochester	Method for altering the lifespan of eukaryotic organisms
JP5369173B2 (ja) *	2008-04-22	2013-12-18	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	キノリン若しくはイソキノリン置換ｐ２ｘ７アンタゴニスト
ES2345527B1 (es) *	2008-10-08	2011-09-08	Hospital Clinic I Provincial De Barcelona	Sustancias bloqueadoras de los canales kv 1.3 para el tratamiento de enfermedades asociadas a hiperplasia de la intima.
EP2593428B1 (en)	2010-07-12	2014-11-19	Pfizer Limited	N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels
CA2828060C (en) *	2011-03-02	2018-11-06	The University Of Tokyo	Endoparasite control agent
EP2773203A1 (en) *	2011-11-02	2014-09-10	Bayer Intellectual Property GmbH	Compounds with nematicidal activity
LT2782565T (lt) *	2011-11-25	2019-12-27	Bayer Intellectual Property Gmbh	Aril- ir hetarilkarboksamidų panaudojimas kaip endoparaziticidų
TW201427947A (zh) *	2012-10-12	2014-07-16	Lundbeck & Co As H	環狀胺
TWI598325B (zh) *	2012-10-12	2017-09-11	Ｈ朗德貝克公司	苯甲醯胺類

2013
- 2013-10-09 TW TW102136498A patent/TWI598325B/zh active
- 2013-10-10 US US14/050,431 patent/US9102591B2/en active Active
- 2013-10-10 AR ARP130103681A patent/AR092973A1/es unknown
- 2013-10-11 PL PL13786633T patent/PL2906546T3/pl unknown
- 2013-10-11 BR BR112015008117A patent/BR112015008117A2/pt not_active IP Right Cessation
- 2013-10-11 EA EA201590562A patent/EA026396B1/ru not_active IP Right Cessation
- 2013-10-11 AU AU2013328584A patent/AU2013328584B2/en not_active Ceased
- 2013-10-11 SI SI201330967T patent/SI2906546T1/en unknown
- 2013-10-11 SG SG11201502680QA patent/SG11201502680QA/en unknown
- 2013-10-11 RS RS20180243A patent/RS56925B1/sr unknown
- 2013-10-11 ME MEP-2018-51A patent/ME02982B/me unknown
- 2013-10-11 SM SM20180136T patent/SMT201800136T1/it unknown
- 2013-10-11 RU RU2015113320A patent/RU2015113320A/ru not_active Application Discontinuation
- 2013-10-11 WO PCT/EP2013/071247 patent/WO2014057078A1/en not_active Ceased
- 2013-10-11 KR KR1020157009187A patent/KR20150067188A/ko not_active Withdrawn
- 2013-10-11 MX MX2015004412A patent/MX369717B/es active IP Right Grant
- 2013-10-11 GE GEAP201313785A patent/GEP201706621B/en unknown
- 2013-10-11 NZ NZ630830A patent/NZ630830A/en not_active IP Right Cessation
- 2013-10-11 HU HUE13786633A patent/HUE038223T2/hu unknown
- 2013-10-11 TR TR2018/02992T patent/TR201802992T4/tr unknown
- 2013-10-11 EP EP13786633.1A patent/EP2906546B1/en active Active
- 2013-10-11 PE PE2015000466A patent/PE20150709A1/es not_active Application Discontinuation
- 2013-10-11 AP AP2015008406A patent/AP2015008406A0/xx unknown
- 2013-10-11 PT PT137866331T patent/PT2906546T/pt unknown
- 2013-10-11 JP JP2015536142A patent/JP6515409B2/ja not_active Expired - Fee Related
- 2013-10-11 DK DK13786633.1T patent/DK2906546T3/en active
- 2013-10-11 HR HRP20180272TT patent/HRP20180272T1/hr unknown
- 2013-10-11 CN CN201380052671.6A patent/CN104884445B/zh not_active Expired - Fee Related
- 2013-10-11 LT LTEP13786633.1T patent/LT2906546T/lt unknown
- 2013-10-11 CA CA2887096A patent/CA2887096C/en active Active
- 2013-10-11 ES ES13786633.1T patent/ES2662523T3/es active Active
2014
- 2014-09-18 NO NO14185271A patent/NO2851818T3/no unknown
2015
- 2015-03-23 IL IL237914A patent/IL237914A0/en unknown
- 2015-03-23 TN TNP2015000107A patent/TN2015000107A1/fr unknown
- 2015-03-26 CR CR20150171A patent/CR20150171A/es unknown
- 2015-03-26 DO DO2015000076A patent/DOP2015000076A/es unknown
- 2015-04-06 PH PH12015500746A patent/PH12015500746A1/en unknown
- 2015-04-08 NI NI201500050A patent/NI201500050A/es unknown
- 2015-04-09 CL CL2015000902A patent/CL2015000902A1/es unknown
- 2015-04-09 EC ECIEPI201513883A patent/ECSP15013883A/es unknown
- 2015-04-10 MA MA37990A patent/MA37990B1/fr unknown
- 2015-06-19 US US14/744,103 patent/US9649308B2/en not_active Expired - Fee Related
2017
- 2017-04-05 US US15/479,972 patent/US10238654B2/en active Active
2018
- 2018-03-09 CY CY20181100291T patent/CY1120008T1/el unknown
- 2018-12-20 JP JP2018238486A patent/JP6632701B2/ja not_active Expired - Fee Related
2019
- 2019-02-25 US US16/283,929 patent/US20200054630A1/en not_active Abandoned

Also Published As

Publication number	Publication date
IL237914A0 (en)	2015-05-31
DOP2015000076A (es)	2015-05-15
EP2906546A1 (en)	2015-08-19
JP2015534576A (ja)	2015-12-03
MX369717B (es)	2019-11-20
KR20150067188A (ko)	2015-06-17
ES2662523T3 (es)	2018-04-06
PT2906546T (pt)	2018-03-14
TR201802992T4 (tr)	2018-03-21
EP2906546B1 (en)	2018-01-10
EA201590562A1 (ru)	2015-07-30
CN104884445A (zh)	2015-09-02
US9649308B2 (en)	2017-05-16
TW201427929A (zh)	2014-07-16
GEP201706621B (en)	2017-02-10
AR092973A1 (es)	2015-05-13
SG11201502680QA (en)	2015-05-28
CY1120008T1 (el)	2018-12-12
ME02982B (me)	2018-10-20
DK2906546T3 (en)	2018-03-12
PL2906546T3 (pl)	2018-05-30
CA2887096A1 (en)	2014-04-17
PH12015500746B1 (en)	2015-05-25
NI201500050A (es)	2016-02-16
US20170202836A1 (en)	2017-07-20
JP6632701B2 (ja)	2020-01-22
CN104884445B (zh)	2018-06-19
US20200054630A1 (en)	2020-02-20
SMT201800136T1 (it)	2018-05-02
RU2015113320A (ru)	2016-11-27
NO2851818T3 (es)	2018-01-06
US20140107340A1 (en)	2014-04-17
AP2015008406A0 (en)	2015-04-30
CR20150171A (es)	2015-07-09
AU2013328584B2 (en)	2017-09-28
HRP20180272T1 (hr)	2018-03-23
WO2014057078A1 (en)	2014-04-17
HK1214242A1 (en)	2016-07-22
US9102591B2 (en)	2015-08-11
PH12015500746A1 (en)	2015-05-25
RS56925B1 (sr)	2018-05-31
ECSP15013883A (es)	2015-12-31
SI2906546T1 (en)	2018-05-31
JP6515409B2 (ja)	2019-05-22
MA20150429A1 (fr)	2015-11-30
BR112015008117A2 (pt)	2017-07-04
MA37990B1 (fr)	2016-12-30
LT2906546T (lt)	2018-03-26
US10238654B2 (en)	2019-03-26
AU2013328584A1 (en)	2015-04-09
EA026396B1 (ru)	2017-04-28
NZ630830A (en)	2016-11-25
PE20150709A1 (es)	2015-05-16
US20150283134A1 (en)	2015-10-08
JP2019081762A (ja)	2019-05-30
CA2887096C (en)	2021-02-16
HUE038223T2 (hu)	2018-10-29
MX2015004412A (es)	2015-06-24
TN2015000107A1 (en)	2016-06-29
TWI598325B (zh)	2017-09-11

Publication	Publication Date	Title
CL2014003136A1 (es)	2015-02-27	Nuevos diazaespirocicloalcanos y azaespirocicloalcanos; composicion farmaceutica que los contiene y usos.
DK3297605T3 (da)	2022-06-07	Topiske, farmaceutiske sammesætninger
DK3253382T3 (da)	2022-02-14	Farmaceutiske sammensætninger til kombinationsterapi
DK3470063T3 (da)	2025-01-20	Farmaceutiske sammensætninger til behandling af cftr-medierede sygdomme
DK3030262T3 (da)	2019-12-02	Kombineret farmaceutisk sammensætning
BR112015002738A2 (pt)	2018-05-22	composto , e , composição farmacêutica
DK3043778T3 (da)	2017-11-27	Farmaceutiske sammensætninger, der indeholder refametinib
DK3341024T3 (da)	2025-01-02	Væskeformige farmaceutiske sammensætninger, som omfatter sglt-2-hæmmere
EP2854781A4 (en)	2016-04-13	XYLITOL-BASED ANTIMUKOSAL COMPOSITIONS AND ASSOCIATED METHODS AND COMPOSITIONS
DK3041476T3 (da)	2020-01-27	Corticosteroid, der indeholder oralt disintegrerende tabletsammensætninger til eosinofil øsofagit
CL2016002569A1 (es)	2017-09-08	Anticuerpos, composiciones farmacéuticas y usos de los mismos
DK3350162T3 (da)	2021-10-04	Mono- eller disubstituerede indolderivater som hæmmere af denguevirusreplikation
CO7061076A2 (es)	2014-09-19	Composición farmacéutica que contiene un derivado de dihidroquinazolina antiviralmente activo
BR112015003259A2 (pt)	2017-08-08	composto, composição farmacêutica, e, composição de vacina.
CL2014002019A1 (es)	2015-01-16	Anticuerpos anti - asic1; composicion farmaceutica que lo comprende y usos de los mismos.
BR112014009889A2 (pt)	2017-04-25	compostos dissubstituídos, compostos e composição farmacêutica
DK3258938T3 (da)	2021-02-01	Phenothiazinanaloger som mitokondrie terapeutiske midler
CL2014003429A1 (es)	2015-03-27	Compuestos especificos derivados de indanosulfamida; composicion farmaceutica que los comprende, utiles en el tratamiento e la epilepsia.
BR112015002824A2 (pt)	2017-08-08	composto, uso de um composto, composição farmacêutica, e, produto farmacêutico de combinação.
DK3191085T3 (da)	2021-06-28	Misbrugsresistente farmaceutiske sammensætninger
CL2014001871A1 (es)	2014-11-03	Compuestos derivados de espiroindolina sustituidos, antagonistas del receptor de la hormona liberadora de gonadotropina (gnrh); y composicion farmaceutica que los comprende.
BR112015010797A2 (pt)	2018-05-15	compostos aniônicos substituídos, e, composição farmacêutica
DK3383397T3 (da)	2021-11-08	Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin
CL2015000359A1 (es)	2015-04-24	Compuestos derivados de pirrolopirazoles sustituidos, bloqueadores del canal de calcio tipo n; y composicion farmaceutica que los comprende.
CL2014001862A1 (es)	2014-11-14	Compuestos derivados de morofolinilo sustituido, útiles como inhibidores de mogat-2; composicion farmaceutica que los comprende; uso en el tratamiento de hipertrigliceridemia.